Search
for
Sort by
Research 121–150 of 1000+
- Modelling androgen synthesis and action during human sexual differentiation
- Comparison of Intra-lesional Methotrexate and Intra-lesional Triamcinolone Acteonid in the treatment of Localized Alopecia Areata
- Gonadal Sex Steroids: Production, Action and Interactions in Mammals
- Anabolic-androgenic steroids. Mechanism of action and clinical effects
- Novel and Established Potassium Channel Openers Stimulate Hair Growth In Vitro: Implications for their Modes of Action in Hair Follicles
- A Review of Platelet-Rich Plasma: History, Biology, Mechanism of Action, and Classification
- Evidence-Based and Potential Benefits of Metformin in the Polycystic Ovary Syndrome: A Comprehensive Review
- Ovarian Hypertension: Polycystic Ovary Syndrome
- Rabson-Mendenhall syndrome: two case reports and a brief review of the literature
- Clinical aspects of the metabolic syndrome
- Observation of phenotypic variation among Indian women with polycystic ovary syndrome (PCOS) from Delhi and Srinagar
- Androgen Induction of Follicular Epithelial Cell Growth Is Mediated via Insulin-like Growth Factor-I from Dermal Papilla Cells
- Untargeted metabolomics analysis of plasma metabolic characteristics in patients with acne and insulin resistance
- Hormonal acne: leading to a paradigm shift in the management of acne
- DHEA : why, when, and how much ? D’après la conférence de Bruno Allolio (Wuerzburg), 50e Journées internationales d’endocrinologie clinique Henri-Pierre KLOTZ, septembre 2007
- Hyperinsulinism, Insulin Resistance and Fertility
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Genetic, hormonal and metabolic aspects of PCOS: an update
- Development of polycystic ovary syndrome: involvement of genetic and environmental factors
- Androgen excess is the key element in polycystic ovary syndrome
- The evaluation of endothelial function with flow-mediated dilatation and carotid intima media thickness in young nonobese polycystic ovary syndrom patients; existence of insulin resistance alone may not represent an adequate condition for deterioration of endothelial function
- Impact of metformin and rosiglitazone treatment on glucose transporter 4 mRNA expression in women with polycystic ovary syndrome.
- Tissue insulin sensitivity and body weight in polycystic ovary syndrome
- Pharmacologic Treatment of Polycystic Ovary Syndrome
- Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities
- Cardiometabolic and neuroimaging correlates of cognitive function in polycystic ovary syndrome
- Calcium and Magnesium levels of Hair tissue and Insulin Sensitivity
- Role of Metformin in Acanthosis Nigricans
- Insulin resistance as risk factor for the development of type 2 diabetes mellitus: a systematic approach
- Workup and Management of Polycystic Ovary Syndrome